PMV Capital Advisers’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
CCA
AWM
KF
OIA
CGA
PMV Capital Advisers's BTAL Position: Q2 2026 in Review
PMV Capital Advisers reduced its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 24% in Q2 2026, selling an estimated $709K and leaving 188,303 shares worth $2.1M. The position accounts for 3.15% of the portfolio, ranked #10.
PMV Capital Advisers first reported a position in BTAL in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.44M in Q1 2026. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.
- PMV Capital Advisers held 188,303 shares of AGF US Market Neutral Anti-Beta Fund worth $2.1M as of Q2 2026.
- PMV Capital Advisers sold 58,318 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $709K.
- AGF US Market Neutral Anti-Beta Fund made up 3.15% of PMV Capital Advisers's portfolio in Q2 2026, its #10 holding.
- PMV Capital Advisers first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2024 and has held it in 7 quarters since.
- PMV Capital Advisers's AGF US Market Neutral Anti-Beta Fund position peaked at $3.44M in Q1 2026.
- 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.
Based on PMV Capital Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.